Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

Home › Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

The CEO who sold Idenix Pharmaceuticals to Merck & Co. in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.

25.11	14
25.11	1/24 308 GTB
25.11	! 3 DVD
25.11	gt scr
25.11	YONEX 3 3E
25.11	1000L
25.11	M2514 Roland/ SH-201
25.11	25th ANNIVERSARY GOLDEN BOX Amazon
More »

je.st